SURVIVAL ANALYSIS AND PROGNOSIS FOR PATIENTS WITH SEROUS AND MUCINOUS BORDERLINE OVARIAN TUMORS: 14-YEAR EXPERIENCE FROM A TERTIARY CENTER IN IRAN

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ZIARI KATAYOUN; SOLEYMANI EBRAHIM; ALIZADEH KAMYAB

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ACTA MEDICA IRANICA Year:2015 | Volume:53 | Issue:4 Page(s): 199-203

Download Full-Text

View:

260

Download:

158

Cites:

Information Journal Paper

Title

SURVIVAL ANALYSIS AND PROGNOSIS FOR PATIENTS WITH SEROUS AND MUCINOUS BORDERLINE OVARIAN TUMORS: 14-YEAR EXPERIENCE FROM A TERTIARY CENTER IN IRAN

Author(s)

ZIARI KATAYOUN | SOLEYMANI EBRAHIM | ALIZADEH KAMYAB | Issue Writer Certificate

Keywords

OVARIAN NEOPLASMS

NEOPLASMS

CYSTIC

MUCINOUS

SEROUS PROGNOSIS

SURVIVAL

Abstract

The aim of this study was to determine the prognosis and SURVIVAL for patients with borderline ovarian tumor (BOT). A retrospective review of 30 patients with serous and MUCINOUS BOT treated at or referred to our institution was performed. Fifteen patients (50%) had serous, and the others had MUCINOUS BOT. About 86% of all patients in both groups were in stage I of the disease. The recurrent disease occurred in 7% and 21% of serous and MUCINOUS tumors, respectively. All recurrences, except one in MUCINOUS tumors, were found in advance stage disease. After a mean of 37 and 52 months follow-up, the overall SURVIVAL was 100% and 93%, and disease-free SURVIVAL was 93% and 79% for serous and MUCINOUS tumors, respectively. In this series, advanced stage was associated with poor prognosis. However, to obtain more accurate information further studies with number of patients and longer follow-up is recommended.

Cites

No record.

References

No record.

Cite

APA: Copy

ZIARI, KATAYOUN, SOLEYMANI, EBRAHIM, & ALIZADEH, KAMYAB. (2015). SURVIVAL ANALYSIS AND PROGNOSIS FOR PATIENTS WITH SEROUS AND MUCINOUS BORDERLINE OVARIAN TUMORS: 14-YEAR EXPERIENCE FROM A TERTIARY CENTER IN IRAN. ACTA MEDICA IRANICA, 53(4), 199-203. SID. https://sid.ir/paper/278702/en

Vancouver: Copy

ZIARI KATAYOUN, SOLEYMANI EBRAHIM, ALIZADEH KAMYAB. SURVIVAL ANALYSIS AND PROGNOSIS FOR PATIENTS WITH SEROUS AND MUCINOUS BORDERLINE OVARIAN TUMORS: 14-YEAR EXPERIENCE FROM A TERTIARY CENTER IN IRAN. ACTA MEDICA IRANICA[Internet]. 2015;53(4):199-203. Available from: https://sid.ir/paper/278702/en

IEEE: Copy

KATAYOUN ZIARI, EBRAHIM SOLEYMANI, and KAMYAB ALIZADEH, “SURVIVAL ANALYSIS AND PROGNOSIS FOR PATIENTS WITH SEROUS AND MUCINOUS BORDERLINE OVARIAN TUMORS: 14-YEAR EXPERIENCE FROM A TERTIARY CENTER IN IRAN,” ACTA MEDICA IRANICA, vol. 53, no. 4, pp. 199–203, 2015, [Online]. Available: https://sid.ir/paper/278702/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops